About The MTC
Led by Dr. David J. Sugarbaker, The Mesothelioma Treatment Center (MTC) at Baylor St. Luke's Medical Center is focused on achieving the best possible outcome for patients with malignant pleural mesothelioma.
High–quality patient care, an outstanding research program and robust patient and family support efforts are the hallmarks of the center.
The personalized treatment given at the Mesothelioma Treatment Center means that each regimen is tailored to the patient based on his/her unique situation. Often, this treatment involves surgery to remove as much of the tumor as possible, followed by chemotherapy and/or radiation to kill any remaining cancer cells. Dr. Sugarbaker and his specialized team have refined the surgical techniques to improve outcomes for mesothelioma patients. Additionally, the clinicians at the MTC are actively engaged in basic and clinical research, which continues to lead to significant improvements in outcomes for patients. For example, a current project of the MTC examines the genetic markers and mechanisms involved in mesothelioma.
Physicians at the Mesothelioma Treatment Center place patient- and family-centered care first, ensuring that patients are active participants in their own treatment. The MTC support staff understands and respects the importance of caring for the emotional needs of the whole family through support groups and other resources.
"My personal goal, and that of the entire team, is on finding a cure. We will continue our battle with this disease and commit to doing our very best for each patient and family we treat." – Dr. David J. Sugarbaker